DNA methylation in GBM presents a significant relationship with disease control and overall survival, and methylation of the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) gene enhances the response to concurrent chemoradiotherapy with temozolomide (TMZ). This evidence concerns the gene MGMT and glioblastoma.